AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals has received an ESG (Environmental, Social, and Governance) rating of 63 from NSE Sustainability Ratings & Analytics Limited for Financial Year 2024-25. The rating was assigned on 7th May 2026. Notably, the company did not engage or commission NSE Sustainability for this rating—it was voluntarily assigned based solely on publicly available information. The company is filing this disclosure under SEBI Regulation 30 for investor awareness.
The ESG rating of 63 suggests above-average sustainability performance, which could attract ESG-focused investors. However, since the rating was not commissioned by the company and based on public data, investors should view it cautiously—the company may not have provided comprehensive ESG data to NSE Sustainability.